Action UCBJY UCB SA
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Société UCB SA OTC Markets

Actions

UCBJY

US9034801012

Produits pharmaceutiques

Temps Différé OTC Markets
Autres places de cotation
 19:27:50 10/06/2024 		Varia. 5j. Varia. 1 janv.
69,98 USD -0,39 % Graphique intraday de UCB SA +0,65 % +60,49 %
20/05 AVIS D'ANALYSTES DU JOUR : Scor, Ubisoft, Nvidia, Richemont, Micron Technology... Our Logo
23/04 Le bric-à-brac de Zonebourse : Tesla (et ARKK) dans le creux de la vague, UCB et le FTSE sur la crête Our Logo

Métier

UCB est une société biopharmaceutique qui se consacre à la recherche et au développement de nouveaux médicaments et de solutions innovantes destinés aux personnes atteintes de maladies graves du système nerveux central ou immunitaire.

Nombre d'employés: 8 767

Ventes par activité

EUR en Millions2022Poids2023Poids Delta
Biopharmaceuticals
100,0 %
5 140 100,0 % 4 867 100,0 % -5,31 %

Ventes par région

EUR en Millions2022Poids2023Poids Delta
United States
50,4 %
2 902 56,5 % 2 454 50,4 % -15,44 %
Other Countries
11,4 %
507 9,9 % 554 11,4 % +9,27 %
Europe - Other
7,5 %
348 6,8 % 365 7,5 % +4,89 %
Germany
6,4 %
330 6,4 % 310 6,4 % -6,06 %
Japan
5,5 %
324 6,3 % 269 5,5 % -16,98 %
Spain
4,6 %
213 4,1 % 224 4,6 % +5,16 %
France (including French Territories)
3,3 %
169 3,3 % 162 3,3 % -4,14 %
China
3,1 %
159 3,1 % 151 3,1 % -5,03 %
Italy
2,9 %
154 3,0 % 143 2,9 % -7,14 %
United Kingdom and Ireland
2,7 %
151 2,9 % 133 2,7 % -11,92 %
Belgium
1,1 %
49 1,0 % 52 1,1 % +6,12 %
Global
1,0 %
-167 -3,2 % 50 1,0 % -129,94 %

Dirigeants

Dirigeants TitreAgeDepuis
Jean-Christophe Tellier CEO
 Chief Executive Officer 65 01/06/11
Sandrine Dufour DFI
 Director of Finance/CFO 57 01/07/20
Dhavalkumar Patel CTO
 Chief Tech/Sci/R&D Officer 63 01/10/17
Kirsten Lund Jurgensen CTO
 Chief Tech/Sci/R&D Officer 65 01/01/19
Iris Löw-Friedrich CTO
 Chief Tech/Sci/R&D Officer 63 01/09/06
Antje Witte IRC
 Investor Relations Contact - -
Dominique Baeten PRN
 Corporate Officer/Principal - -
Thomas Debeys AUD
 Comptroller/Controller/Auditor - -
Jean Fleurial HRO
 Human Resources Officer 59 01/09/17
Emmanuel Caeymaex PRN
 Corporate Officer/Principal - 01/03/94

Administrateurs

Administrateurs TitreAgeDepuis
Ulf Arne Wiinberg BRD
 Director/Board Member 66 28/04/16
Dame Davies BRD
 Director/Board Member 73 01/01/14
Jean-Christophe Tellier CEO
 Chief Executive Officer 65 01/06/11
Cyril Janssen BRD
 Director/Board Member 53 01/01/15
Jan Berger BRD
 Director/Board Member 67 01/04/19
Jonathan Peacock CHM
 Chairman 66 01/01/21
Maëlys Castella BRD
 Director/Board Member 58 01/01/23
Jonkheer Cédric van Rijckevorsel BRD
 Director/Board Member 54 24/04/14
Charles-Antoine Janssen BRD
 Director/Board Member 53 01/01/01
Pierre Gurdjian BRD
 Director/Board Member 63 28/04/16

Classe d'actions

VoteNombreFlottantAutocontrôleFlottant Total
Action A 1 194 505 658 119 501 352 ( 61,44 %) 4 755 075 ( 2,445 %) 61,44 %

Actionnaires

NomActions%Valorisation
FINANCIÈRE DE TUBIZE S.A.
36,04 %
70 090 611 36,04 % 9 334 M $
Wellington Management Co. LLP
6,555 %
12 749 947 6,555 % 1 698 M $
UCB
2,445 %
4 755 075 2,445 % 633 M $
FMR Investment Management (UK) Ltd.
0,4947 %
962 306 0,4947 % 128 M $
Wellington Management International Ltd.
0,3981 %
774 419 0,3981 % 103 M $
Mackenzie Investments Europe Ltd.
0,2381 %
463 204 0,2381 % 62 M $
Ibercaja Gestión SGIIC SA
0,2159 %
420 015 0,2159 % 56 M $
State Street Global Advisors Ltd.
0,1971 %
383 325 0,1971 % 51 M $
Argenta Spaarbank NV
0,1493 %
290 401 0,1493 % 39 M $
Apo Asset Management GmbH
0,1491 %
289 979 0,1491 % 39 M $
NomActions%Valorisation
RhumbLine Advisers LP
0,000990 %
3 852 0,000990 % 258 123 $
GAMMA Investing LLC
0,000032 %
125 0,000032 % 8 376 $
PNC Investments LLC
0,000001 %
5 0,000001 % 335 $

Participations

NomActions%Valorisation
UCB
2,44%
 4 755 075 2,44% 664 105 329 $

Coordonnées société

UCB SA

Allée de la Recherche, 60

1070, Brussels

+32 2 559 99 99

http://www.ucb.com
Adresse UCB SA(UCBJY)

Sociétés du groupe

NomCatégorie et Secteur
UCB Manufacturing Ireland Ltd.
UCB Fipar SA
Logo UCB Fipar SA

UCB Fipar SA

Financial ConglomeratesFinance

Part of UCB SA, UCB Fipar SA is an investment holding Belgian company. The company is based in Anderlecht, Belgium. UCB Fipar was founded in 1947.

Financial Conglomerates
UCB Ventures Belgium SA
Investment Managers
UCB Pharma GmbH
Logo UCB Pharma GmbH

UCB Pharma GmbH

Pharmaceuticals: MajorHealth Technology

UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany.

Pharmaceuticals: Major
UCB Pharma SA (Belgium)
Logo UCB Pharma SA (Belgium)

UCB Pharma SA (Belgium)

Pharmaceuticals: MajorHealth Technology

UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium.

Pharmaceuticals: Major
UCB Ventures SA
Investment Managers
Ucb Belgium SA
Logo Ucb Belgium SA

Ucb Belgium SA

Pharmaceuticals: MajorHealth Technology

Part of UCB SA, UCB Belgium SA is a Belgian bio-pharmaceutical company that focuses on neurology and immunology. The company is based in Brussels, Belgium. The company was founded by Emmanuel Janssen.

Pharmaceuticals: Major
UCB Pharma Ltd.
Logo UCB Pharma Ltd.

UCB Pharma Ltd.

Pharmaceuticals: MajorHealth Technology

UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom.

Pharmaceuticals: Major
UCB Biopharma SRL
Logo UCB Biopharma SRL

UCB Biopharma SRL

Medical DistributorsDistribution Services

Part of UCB SA, UCB Biopharma SRL is a Belgian pharmaceutical company founded in 2013. The company is based in Brussels, Belgium. UCB Biopharma specializes in the development of treatments for various medical conditions, including axial spondyloarthritis, psoriatic arthritis, and other health issues. The company also manages the UCB Community Health Fund and holds an annual shareholders meeting.

Medical Distributors

Secteur

Santé
Recherche pharmaceutique et médicale
Produits pharmaceutiques
Produits pharmaceutiques
Biopharmacies

Ventes par région

Notations pour UCB SA

Note Trading
Note Investissement
ESG Refinitiv
Plus de notations

Consensus des Analystes

Vente
Consensus
Achat
Recommandation moyenne
ACCUMULER
Nombre d'Analystes
19
Dernier Cours de Cloture
130 EUR
Objectif de cours Moyen
126,4 EUR
Ecart / Objectif Moyen
-2,78 %
Consensus

Révisions de BNA

Révisions des Estimations

Bénéfices trimestriels - Taux de surprise

Agenda de la société

Secteur Biopharmacies

Varia. 1 janv. Capi.
CSL LIMITED Action CSL Limited
+0,82 % 91,94 Md
SAMSUNG BIOLOGICS CO.,LTD. Action Samsung Biologics Co.,Ltd.
-3,16 % 38,74 Md
BIOMARIN PHARMACEUTICAL INC. Action BioMarin Pharmaceutical Inc.
-12,60 % 15,32 Md
INCYTE CORPORATION Action Incyte Corporation
-5,76 % 13,3 Md
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Action Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11,38 % 11,65 Md
ALTEOGEN INC. Action ALTEOGEN Inc.
+156,85 % 10,37 Md
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Action Chongqing Zhifei Biological Products Co., Ltd.
-49,84 % 10,12 Md
SWEDISH ORPHAN BIOVITRUM AB Action Swedish Orphan Biovitrum AB
+2,32 % 9,06 Md
INNOVENT BIOLOGICS, INC. Action Innovent Biologics, Inc.
-16,26 % 7,46 Md
Biopharmacies
  1. Bourse
  2. Actions
  3. Action UCB
  4. Action UCBJY
  5. Société UCB SA